Where is the live CopyMark page for USPTO serial 74252992?

The live record is at https://getcopymark.com/trademark/74252992. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns STREPTAMATE?

According to the public USPTO record for serial number 74252992, the listed owner(s) include: ASTRA PHARMACEUTICAL PRODUCTS, INC., ASTRA PHARMACEUTICAL PRODUCTS, INC..

What is USPTO serial number 74252992?

Serial number 74252992 is the USPTO application identifier for the mark STREPTAMATE. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover STREPTAMATE?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: STREPTAMATE Serial# 74252992 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

Q: What is the current status of STREPTAMATE?

STREPTAMATE (74252992) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STREPTAMATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

ASTRA PHARMACEUTICAL PRODUCTS, INC.
Westborough, MA
Other trademarks owned by ASTRA PHARMACEUTICAL PRODUCTS, INC.
ASTRA PHARMACEUTICAL PRODUCTS, INC.
Westborough, MA
Other trademarks owned by ASTRA PHARMACEUTICAL PRODUCTS, INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew V. Galway

ANDREW V GALWAY LIDDY, SULLIVAN, GALWAY, BEGLER & PEROFF41 MADISON AVENEW YORK, NY 10010UNITED STATES

Goods and services

Class	Description	Status	First use
005	streptokinase infusion kit consisting essentially of a single does vial of streptokinase, alcohol pads, sterile syringe, single dose vial of 0.9% sodium chloride (normal saline solution), sterile transfer needles, one elastomeric infusion system and a patient identification label, for the treatment of acute evolving transmural myocardial infarction	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Aug 17, 1993	ABN1	ABANDONMENT - EXPRESS MAILED	—
May 25, 1993	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 2, 1993	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 1993	NPUB	NOTICE OF PUBLICATION	—
Dec 17, 1992	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Nov 30, 1992	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
May 27, 1992	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 1992	DOCK	ASSIGNED TO EXAMINER	—

STREPTAMATE